Psychiatry Perspective

• Tragic End to a Fairytale: The Case I Wish I Could Rewrite A patient of mine who had Parkinson's disease and depression called me at home. She needed a next-day appointment. I made her one. But I wish that I'd done more.
  Medscape Family Medicine, May 17, 2022
• Treatment-Resistant Major Depressive Disorder   A 22-year-old woman with a history of major depression presents at the emergency department with new-onset suicidal ideation after the breakup of a relationship. Her current medications are evaluated and considerations for her follow-up care and treatment options are discussed.
  Medscape, May 17, 2022
• When Words Are Not Enough A psychologist shares her experience exploring a common thread tying patient and provider together.
  Medscape Blogs, May 16, 2022
• Medscape Psychiatrist Compensation Report 2022 Medscape's Psychiatrist Compensation Report 2022 explores income sources, pay gaps, and attitudes about work as COVID's impact on medical practices declines.
  Medscape Features Slideshows, May 13, 2022
• Paxlovid Rebound: What Is Happening?   Dr Paul Auwaerter discusses Paxlovid rebound and the use of investigational drugs.
  Medscape Infectious Diseases, May 13, 2022
• Yes, Say Gay: Small Steps to Improving LGBTQ+ Patient Care One psychologist discusses how the US healthcare system fails the LGBTQ+ community and offers ways to address this in the clinic.
  Medscape Psychiatry, May 13, 2022
• Running to the Top: Exercise and Mental Health The secret to a healthy life? Exercise.
  Medscape Blogs, May 12, 2022
• Anorexia Nervosa in Adolescent Patients: What You Need to Know Here we will review the epidemiology, diagnosis, and treatment of anorexia, with an emphasis on what pediatricians need to know to screen and to facilitate treatment.
  Medscape Pediatrics, May 12, 2022
• The Case for Post-COVID Steroids   Dr F. Perry Wilson cautions against changing practice on the basis of a single study.
  Medscape, May 12, 2022
• Medicare Is Right Not to Pay for Costly Alzheimer's Drug: Ethicist   Prof Art Caplan discusses Medicare's decision on paying for the use of the Alzheimer's drug Aduhelm.
  Medscape Business of Medicine, May 11, 2022
• Episode 2: The Role of Transcranial Magnetic Stimulation in Major Depressive Disorder   Madhukar Trivedi, MD, and Jonathan Downar, MD, review the evidence on the efficacy of transcranial magnetic stimulation as a treatment for major depressive disorder.
  Medscape, May 11, 2022
• Episode 1: Novel Treatments in MDD: Ketamine and Esketamine   Madhukar Trivedi, MD, and Manish Jha, MD, MBBS, review the evidence on the efficacy of esketamine and ketamine as a treatment for major depressive disorder.
  Medscape, May 11, 2022
• Sleep More, Weigh Less? Dr Aaron Holley looks at the current association of weight gain with sleep deprivation.
  Medscape Critical Care, May 10, 2022
• Five New Neurology Studies: Possible Breakthroughs, Some Failures   Dr Christoph Diener on promising early results in muscular dystrophy and Creutzfeldt-Jakob disease, and discouraging ones for aducanumab.
  Medscape Neurology, May 09, 2022
• Hope, Hype, and the Problem With New Drug Development Desperation for neurologic disorders is leading us away from evidence-based practices.
  Medscape Neurology, May 06, 2022
• Burnout: Is Leaving Your Current Job the Answer? Burnout is real, but if you have your priorities set and clear, it is easy to negotiate.
  Medscape Blogs, May 06, 2022
• TV Doctors: I'd Like to Have a Word With You Hollywood needs to hold health professionals to higher standards.
  Medscape Blogs, May 05, 2022
• Key Studies in Migraine From AAN 2022   Dr Jessica Ailani reports key studies in migraine from AAN 2022, including a potential biomarker for migraine progression, analyses of the CaMEO study, and pregnancy outcomes in migraine patients.
  Medscape, May 03, 2022
• Infographic: Burnout and Depression Hit Physicians Hard Physicians reveal the impacts of burnout and depression on their work and personal lives, where they turn for help, and whether the issues affect patient care.
  Medscape, April 29, 2022
• It's Time to Shame the Fat Shamers People with obesity are more likely to receive substandard treatment from their healthcare providers. Is bias toward people with obesity affecting your treatment of these patients?
  Medscape Diabetes & Endocrinology, April 28, 2022